PRIMMUNE THERAPEUTICS
Primmune Therapeutics is developing small molecule, orally-administered toll-like receptor 7 (TLR7) agonists to attack tumors and potentiate adaptive cancer immunotherapies, such as checkpoint inhibitors, to improve overall response rates and treatment durability.
PRIMMUNE THERAPEUTICS
Industry:
Biotechnology Health Care
Founded:
2017-01-01
Address:
San Diego, California, United States
Country:
United States
Website Url:
http://www.primmunerx.com
Total Employee:
1+
Status:
Active
Total Funding:
48.33 M USD
Similar Organizations
Combinati
Combinati is a biotechnology company based in Palo Alto.
Congruence Therapeutics
Congruence Therapeutics operates as a biotechnology company.
Cygnal Therapeutics
Cygnal Therapeutics is a biotechnology company
Faze Medicines
Faze Medicines is a biotechnology company.
Immunicom
Immunicom is a biotechnology company.
KBP Biosciences
A multinational clinical stage biotechnology company.
Libra Therapeutics
Libra Therapeutics is a biotechnology company.
Neomorph
Neomorph is a biotechnology company.
RubrYc Therapeutics
RubrYc Therapeutics is a biotechnology company.
Telum Therapeutics
Telum Therapeutics is a biotechnology company.
Current Advisors List
Current Employees Featured
Founder
Investors List
Bioqube Ventures
Bioqube Ventures investment in Series A - Primmune Therapeutics
BioRock Ventures Name
BioRock Ventures Name investment in Series A - Primmune Therapeutics
Samsara BioCapital
Samsara BioCapital investment in Series A - Primmune Therapeutics
Oberland Capital
Oberland Capital investment in Series A - Primmune Therapeutics
Charlie McDermott
Charlie McDermott investment in Series A - Primmune Therapeutics
Polaris Partners
Polaris Partners investment in Series A - Primmune Therapeutics
BioBrit
BioBrit investment in Series A - Primmune Therapeutics
CAM Capital
CAM Capital investment in Series A - Primmune Therapeutics
Charlie McDermott
Charlie McDermott investment in Seed Round - Primmune Therapeutics
CAM Capital
CAM Capital investment in Seed Round - Primmune Therapeutics
Official Site Inspections
http://www.primmunerx.com
- Host name: 152.0.198.104.bc.googleusercontent.com
- IP address: 104.198.0.152
- Location: Mountain View United States
- Latitude: 37.4043
- Longitude: -122.0748
- Metro Code: 807
- Timezone: America/Los_Angeles
- Postal: 94043
More informations about "Primmune Therapeutics"
Primmune Therapeutics - Crunchbase Company Profile …
Primmune Therapeutics is developing small molecule, orally-administered toll-like receptor 7 (TLR7) agonists to attack tumors and potentiate adaptive cancer … See details»
Overview, News & Similar companies - ZoomInfo.com
Mar 20, 2024 View Primmune Therapeutics (www.primmunerx.com) location in California, United States , revenue, industry and description. Find related and similar companies as well as … See details»
Primmune Therapeutics - LinkedIn
Primmune Therapeutics is developing an orally administered TLR7 agonist to stimulate innate immunity in cancer immunotherapy. Our goal is to improve the response rate of patients to … See details»
Primmune Therapeutics Information - RocketReach
Primmune Therapeutics is a Biotechnology Research company_reader located in San Diego, California with 10 employees. Find top employees, contact details and business statistics at … See details»
Primmune Therapeutics Company Profile | Management and
Find contact information for Primmune Therapeutics. Learn about their Business Services market share, competitors, and Primmune Therapeutics's email format. See details»
Home - Primmune
PRTX007: Clinical Validation of Primmune’s TLR7 Agonist PRTX007 is a tuned TLR7 agonist and Primmune’s lead clinical development candidate. PRTX007 is administered orally and uniquely … See details»
Primmune Therapeutics 2025 Company Profile: Valuation
Information on valuation, funding, cap tables, investors, and executives for Primmune Therapeutics. Use the PitchBook Platform to explore the full profile. See details»
Primmune Therapeutics - Craft
Primmune Therapeutics is a company that provides drug design and development solutions. It offers a toll-like receptor 7 (TLR7) agonist to stimulate innate immunity in cancer immunotherapy. See details»
Primmune Therapeutics, Inc. - VentureRadar
Associated sectors: Oncology; Biotechnology; Biotech; Small Molecule Pharmaceuticals; 858 Therapeutics USA Privately Held 858 Therapeutics is a biotechnology and drug discovery … See details»
Primmune Therapeutics - 2025 Company Profile - Tracxn
May 8, 2025 Primmune Therapeutics - Developer of immunotherapies for treating cancer. Raised a total funding of $51.4M over 7 rounds from 10 investors. See details»
Primmune Therapeutics Overview | SignalHire Company Profile
Primmune Therapeutics is a private company that has been in the industry for 7 years. The company currently specializes in the Biotechnology, Biotechnology areas. The position of the … See details»
Primmune Therapeutics, Inc. - Drug pipelines, Patents, Clinical …
Explore Primmune Therapeutics, Inc. with its drug pipeline, therapeutic area, technology platform, 8 news, Disease Domain:Neoplasms, Infectious Diseases, Technology ... See details»
Primmune Therapeutics Research by SuperAGI
```report ## Company Overview **Primmune Therapeutics** is a biotechnology company based in San Diego, California, specializing in the development of therapies that harness the innate … See details»
Primmune Therapeutics - F6S
Primmune Therapeutics - Primmune Therapeutics is developing an orally administered TLR7 agonist to stimulate innate immunity in cancer immunotherapy. Our goal is to improve the … See details»
Primmune Therapeutics Inc. - life-sciences-usa.com
Life Sciences Business Intelligence Web Portal for North America, Europe and Israel See details»
Primmune Therapeutics Company Overview, Contact Details
Nov 4, 2021 Learn more about Primmune Therapeutics's company details, contact information, competitors, and more. Find accurate contact data easily with LeadIQ. Book a demo today. See details»
Primmune Therapeutics - HigherGov
Primmune Therapeutics (UEI RCE3KW671H83, CAGE 8J8L4) based in Carlsbad CA federal contracts, grants, registrations, vehicles, partnerships, and analysis See details»
Primmune Therapeutics’s Competitors, Revenue, Number of
Primmune Therapeutics’s Profile, Revenue and Employees. Primmune is a California-based biotechnology company that researches and develops T cell-based immunotherapies for the … See details»
Primmune Therapeutics, Inc. - BIO CEO & Investor Conference | BIO
The Biotechnology Innovation Organization is the world's largest biotech trade association. Learn about BIO, register for events and explore member services. See details»
Primmune Therapeutics: Employee Directory | ZoomInfo.com
Primmune Therapeutics Employee Directory Primmune Therapeutics corporate office is located in 2333 State St Ste 203, Carlsbad, California, 92008, United States and has 8 employees. See details»